- ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article
Expanding the search for therapeutic antibodies
Invenra’s new proprietary platform, which combines cell-free protein expression with extreme miniaturization, enables the direct phenotypic interrogation of large numbers of full-length antibodies and their derivatives, empowering the discovery of next-generation biologics.